Germany: Pharmaceutical Corden Pharma Inaugurates Development Suite for Dosage Products

Editor: Alexander Stark

Corden Pharma announced the completion of its newest early development suite for highly potent, oral solid dosage products in Plankstadt.

Related Vendors

Corden Pharma Plankstadt announces completion of a new development area featuring expanded capabilities for 5 – 20 kg scale manufacturing of Highly Potent compounds.
Corden Pharma Plankstadt announces completion of a new development area featuring expanded capabilities for 5 – 20 kg scale manufacturing of Highly Potent compounds.
(Source: Corden Pharma)

Frankfurt/Germany — Plankstadt’s setup has the engineering controls to allow for the production of compounds with various potencies and degrees of containment, the company announced. The manufacturer claims that all steps can be performed, starting from dispensing to film coating, in an engineering controlled environment protecting employees, product and environment.

The new facility allows for the production of small batches, from 100 g to approximately 1,000 g.

The investment in Plankstadt is the latest of several announced investments made by the company during 2017, where further capacity expansion and capabilities were installed in Colorado and Plankstadt to meet growing customer demand.

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy.

Unfold for details of your consent

(ID:44898189)